ABCA4 p.Leu2060Arg
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 21330655
[PubMed]
Aguirre-Lamban J et al: "Further associations between mutations and polymorphisms in the ABCA4 gene: clinical implication of allelic variants and their role as protector/risk factors."
No.
Sentence
Comment
72
Mutations and Polymorphisms in the Patient Cohort ABCA4 mutation screening demonstrated that the most frequent (Ͼ5%) disease-associated alleles were the following: p.Arg1129Leu, p.Gly1961Glu, p.Arg602Trp, c.3211insGT, and p.Leu2060Arg (Table 1; Fig. 1).
X
ABCA4 p.Leu2060Arg 21330655:72:230
status: NEW83 Most Frequent ABCA4 Disease-Associated Alleles Identified in the Patient Cohort Exon Nucleotide Change Aminoacid Change Patients n (%) Allele Frequency n (%) Controls n (%) Allele Frequency n (%) P 23 c.3386GϾT p.Arg1129Leu 34 (26.6) 38 (14.8) 0 (0.0) 0 (0.0) 0.000 42 c.5882GϾA p.Gly1961Glu 18 (14.1) 18 (7.0) 1 (1.2) 1 (0.6) 0.001 13 c.1804CϾT p.Arg602Trp 8 (6.3) 9 (3.5) 0 (0.0) 0 (0.0) 0.020 22 c.3211insGT Frameshift 7 (5.5) 7 (2.7) 0 (0.0) 0 (0.0) 0.029 45 c.6179TϾG p.Leu2060Arg 7 (5.5) 7 (2.7) 0 (0.0) 0 (0.0) 0.029 Note that only the p.Gly1961Glu substitution was identified in both patients and control groups.
X
ABCA4 p.Leu2060Arg 21330655:83:499
status: NEW96 p.Leu2060Arg The fifth most frequently detected mutation was p.Leu2060Arg (5.5%) (Table 1).
X
ABCA4 p.Leu2060Arg 21330655:96:2
status: NEWX
ABCA4 p.Leu2060Arg 21330655:96:63
status: NEW98 However, p.His423Arg was less frequently detected among patients harboring p.Leu2060Arg, since the frequency of this occurrence was 14.3% (P ϭ 0.05) (Table 3).
X
ABCA4 p.Leu2060Arg 21330655:98:77
status: NEW109 Association between the Most Frequent ABCA4 Polymorphisms and Mutations Patients Variants Frequency P Status Predicted Effect Mutation, n (%) p.Arg1129Leu 34 (26.6) Present polymorphisms p.His423Arg 94.1% 0.000 Associated Risk IVS33؉48C>T 100% 0.011 Associated Risk IVS10ϩ5delG 20.6% 0.049 Associated Protector p.Leu1938Leu 17.6% 0.033 Associated Protector p.Ser2255Ile 2.9% 0.054 Associated Protector Mutation, n (%) p.Gly1961Glu 18 (14.1) Present polymorphisms p.Pro1948Pro 94.7% 0.000 Associated Risk p.Leu1938Leu 89.5% 0.000 Associated Risk p.Asp2095Asp 78.9% 0.000 Associated Risk IVS48؉21C>T 70.0% 0.000 Associated Risk IVS10؉5delG 57.9% 0.008 Associated Risk p.His423Arg 31.6% 0.016 Associated Protector p.Asn1868Ile 18.7% 0.039 Associated Protector Mutation, n (%) p.Arg602Trp 8 (6.3%) Present polymorphisms p.Arg943Gln 62.5% 0.000 Associated Risk p.Pro1401Pro 25% 0.044 Associated Protector p.Leu1938Leu 0% 0.041 Associated Protector Mutation, n (%) c.3211insGT 7 (5.5%) Present polymorphisms p.His423Arg 100% 0.021 Associated Risk p.Asn1868Ile 100% 0.000 Associated Risk IVS10ϩ5delG 0% 0.047 Associated Protector Mutation, n (%) p.Leu2060Arg 7 (5.5%) Present polymorphisms p.Leu1938Leu 100% 0.000 Associated Risk p.Pro1948Leu 100% 0.000 Associated Risk p.His423Arg 14.3% 0.019 Associated Protector TABLE 4.
X
ABCA4 p.Leu2060Arg 21330655:109:1171
status: NEW114 This is the case of the p.His423Arg polymorphism and the p.Gly1961Glu and p.Leu2060Arg mutations (P ϭ 0.023; Table 3); in other cases, however, the same polymorphism was found in association with the pArg1129Leu and c.3211insGT mutations.
X
ABCA4 p.Leu2060Arg 21330655:114:76
status: NEW116 As expected, no mutations were present in control samples, with the exception of p.Gly1961Glu (1.19%).
X
ABCA4 p.Leu2060Arg 21330655:116:2
status: NEWX
ABCA4 p.Leu2060Arg 21330655:116:63
status: NEW118 The p.Gly1961Glu variant was found in 18 (out of 128) STGD patients and was considered a moderate allele.9 However, there is no linkage disequilibrium, since five out of 18 STGD patients did not carry the IVS48ϩ21CϾT polymorphism.
X
ABCA4 p.Leu2060Arg 21330655:118:77
status: NEW129 The p.Arg943Gln polymorphism is in linkage disequilibrium with the p.Arg602Trp mutation in Spanish STGD (P Ͻ 0.001, Table 3).
X
ABCA4 p.Leu2060Arg 21330655:129:1171
status: NEW73 Mutations and Polymorphisms in the Patient Cohort ABCA4 mutation screening demonstrated that the most frequent (b0e;5%) disease-associated alleles were the following: p.Arg1129Leu, p.Gly1961Glu, p.Arg602Trp, c.3211insGT, and p.Leu2060Arg (Table 1; Fig. 1).
X
ABCA4 p.Leu2060Arg 21330655:73:230
status: NEW84 Most Frequent ABCA4 Disease-Associated Alleles Identified in the Patient Cohort Exon Nucleotide Change Aminoacid Change Patients n (%) Allele Frequency n (%) Controls n (%) Allele Frequency n (%) P 23 c.3386Gb0e;T p.Arg1129Leu 34 (26.6) 38 (14.8) 0 (0.0) 0 (0.0) 0.000 42 c.5882Gb0e;A p.Gly1961Glu 18 (14.1) 18 (7.0) 1 (1.2) 1 (0.6) 0.001 13 c.1804Cb0e;T p.Arg602Trp 8 (6.3) 9 (3.5) 0 (0.0) 0 (0.0) 0.020 22 c.3211insGT Frameshift 7 (5.5) 7 (2.7) 0 (0.0) 0 (0.0) 0.029 45 c.6179Tb0e;G p.Leu2060Arg 7 (5.5) 7 (2.7) 0 (0.0) 0 (0.0) 0.029 Note that only the p.Gly1961Glu substitution was identified in both patients and control groups.
X
ABCA4 p.Leu2060Arg 21330655:84:499
status: NEW134 This is the case of the p.His423Arg polymorphism and the p.Gly1961Glu and p.Leu2060Arg mutations (P afd; 0.023; Table 3); in other cases, however, the same polymorphism was found in association with the pArg1129Leu and c.3211insGT mutations.
X
ABCA4 p.Leu2060Arg 21330655:134:76
status: NEW
PMID: 17325136
[PubMed]
Valverde D et al: "Spectrum of the ABCA4 gene mutations implicated in severe retinopathies in Spanish patients."
No.
Sentence
Comment
56
TABLE 1. Genetic Analyses of ABCA4 Mutations in Three Families with Autosomal Dominant Macular Dystrophy Family Allele 1 Allele 2 Haplotype AnalysisNucleotide Change Amino Acid Change Nucleotide Change Amino Acid Change ADDM-59 [5582G3A; 6764G3T] [G1961E; S22551] Excluded ADDM-92 466A3G I156V Not done ADDM-105 2828G3A R943Q Not done No change has been detected as allele 2.
X
ABCA4 p.Leu2060Arg 17325136:56:695
status: NEW57 TABLE 2. Genetic Analyses of ABCA4 Mutations in 13 arCRD Families Family Allele 1 Allele 2 Haplotype AnalysisNucleotide Change Amino Acid Change Nucleotide Change Amino Acid Change ARDM-79 2888delG Frameshift 2888delG Frameshift Cosegregates ARDM-85 6764G3T S2255I (likely nonpathogenic) Not detected Not done* ARDM-86 2888delG Frameshift 2888delG Frameshift Cosegregates ARDM-99 4297G3A V1433I Not detected Not done* ARDM-126 [2828G3A; 5929G3A] [R943Q; G1977S] [2828G3A; 5929G3A] [R943Q; G1977S] Cosegregates ARDM-133 32T3C L11P 2888delG Frameshift Cosegregates ARDM-134 2828G3A R943Q Excluded ARDM-174 4918C3T R1640W c.6147؉2T3A Splice Cosegregates ARDM-176 2888delG Frameshift 6179T3G L2060R Cosegregates RP-267 5041del 15 pb Frameshift 5041del 15 pb Frameshift Cosegregates RP-577 1140T3A N380K Not detected Not done* SRP-964 2828G3A R943Q Not detected Not done* B210 2828G3A R943Q 2701A3G T901A Not done* The mutation detected by dHPLC is in bold.
X
ABCA4 p.Leu2060Arg 17325136:57:694
status: NEW108 In the two 2888delG compound heterozygous families, one of them showed the missense mutation L11P, which affects a conserved amino acid localized in the intracytoplasmic compartment,8 as a second allele, and the other family harbored the L2060R mutation, which produces an alteration in the charge of the mutated amino acid that has been associated with the CRD phenotype.20 In this work, we found that the diagnosis of the proband from family ARDM-79 had changed from arSTGD to arCRD.
X
ABCA4 p.Leu2060Arg 17325136:108:238
status: NEW106 In the two 2888delG compound heterozygous families, one of them showed the missense mutation L11P, which affects a conserved amino acid localized in the intracytoplasmic compartment,8 as a second allele, and the other family harbored the L2060R mutation, which produces an alteration in the charge of the mutated amino acid that has been associated with the CRD phenotype.20 In this work, we found that the diagnosis of the proband from family ARDM-79 had changed from arSTGD to arCRD.
X
ABCA4 p.Leu2060Arg 17325136:106:238
status: NEW
PMID: 11385708
[PubMed]
Paloma E et al: "Spectrum of ABCA4 (ABCR) gene mutations in Spanish patients with autosomal recessive macular dystrophies."
No.
Sentence
Comment
41
Mutations L686S, c.2888delG, T1253L, c.4253 +5G>A, N1799D, N1805D, L1940P , and L2060R were confirmed by TaqI, Sau96I, HgaI, HhaI, MboI, TaqI, HaeIII, and MspI digestion, respectively.
X
ABCA4 p.Leu2060Arg 11385708:41:80
status: NEW59 Pathogenic Mutations In the absence of a functional assay, it is difficult to relate the structural alteration with the TABLE 1. Summary of the Pathogenic Variants Found in the Screening of the ABCA4 Gene Family (NAS) Paternal allele (E) Maternal allele (E) Onset (years) Phenotype SB1 c.3211-3212insGT (22) R212C (6) 9 CRD M266 (2) c.4253+5G>A (28) L2060R (46) 7/4 CRD SM3 [R152Q (5); R2107H (46)] [R152Q (5); R2107H (46)] 7 STGD SZ2 L1940P (41) ND 8 STGD SM1 N1799D (38) ND 9 STGD SM2 c.2888delG (19) [R1055W (21); C.2588G>C (17)] 11 STGD SP1 ND ND 12 STGD SZ3 ND ND 12 STGD M280 N1805D (39) N1805D (39) 14 STGD SB2 (2) R1108C (22) L686S (14) 18/11 STGD SZ4 ND ND 20/28 FFM SP2 ND ND 21 FFM SM4 [T1253L (25); G1961E (42)] ND 38 FFM SZ1 L1940P (41) ND 28 FFM Novel putative pathogenic variants are depicted in bold type and their corresponding nucleotide changes are as follows: L686S=c.2057T>C; R1055W=c.3163C>T; T1253L=c.3758C>T; N1799D=c.5396A>G; N1805D=c.5413A>G; L1940P=c.5819T>C; L2060R=c.6179T>G.
X
ABCA4 p.Leu2060Arg 11385708:59:350
status: NEW106 In family M266, the association of c.4253+ 5G>A and L2060R with CRD suggests that both could be ranked as moderately severe mutations.
X
ABCA4 p.Leu2060Arg 11385708:106:52
status: NEW